Warning! GuruFocus detected
1 Medium warning sign
with 4583.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Chiome Bioscience Inc
NAICS : 325412
ISIN : JP3205350006
Description
Chiome Bioscience Inc is a Japanese based company engaged in the manufacture and sale of antibody drugs through the Autonomous Diversifying Library System. The business activity of the group is operated through Drug Discovery Alliance, Lead Antibody Licensing, and Licensing Out Platform Technology segments. The Drug Discovery Alliance segment partners with pharmaceutical companies to develop and create lead antibody drugs. The Lead Antibody Licensing Out segment is engaged in the production of specific antibodies against antigens and early licensing out to pharmaceutical manufacturers and the Licensing Out Platform Technology segment conducts research and development through the ADLib System. Geographically all the activities are functioned through Japan.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.78 | |||||
| Equity-to-Asset | 0.69 | |||||
| Debt-to-Equity | 0.27 | |||||
| Debt-to-EBITDA | -0.26 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 10.56 | |||||
| Beneish M-Score | -3.29 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 0.9 | |||||
| 3-Year EBITDA Growth Rate | 12 | |||||
| 3-Year EPS without NRI Growth Rate | 11.9 | |||||
| 3-Year FCF Growth Rate | 17.1 | |||||
| 3-Year Book Growth Rate | -34.6 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 29.04 | |||||
| 9-Day RSI | 30.78 | |||||
| 14-Day RSI | 31.71 | |||||
| 3-1 Month Momentum % | -40.15 | |||||
| 6-1 Month Momentum % | 31.97 | |||||
| 12-1 Month Momentum % | 12.59 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.29 | |||||
| Quick Ratio | 3.17 | |||||
| Cash Ratio | 2.55 | |||||
| Days Inventory | 81.55 | |||||
| Days Sales Outstanding | 45.34 | |||||
| Days Payable | 48.13 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -10 | |||||
| Shareholder Yield % | -0.61 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 55.28 | |||||
| Operating Margin % | -191.9 | |||||
| Net Margin % | -190.76 | |||||
| FCF Margin % | -182.05 | |||||
| ROE % | -96.06 | |||||
| ROA % | -65.89 | |||||
| ROIC % | -232.74 | |||||
| 3-Year ROIIC % | -33.02 | |||||
| ROC (Joel Greenblatt) % | -458.14 | |||||
| ROCE % | -91.19 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 13.13 | |||||
| PB Ratio | 7.63 | |||||
| Price-to-Tangible-Book | 7.64 | |||||
| EV-to-EBIT | -8.22 | |||||
| EV-to-EBITDA | -8.22 | |||||
| EV-to-Revenue | 15.59 | |||||
| EV-to-FCF | -8.56 | |||||
| Price-to-GF-Value | 1.19 | |||||
| Price-to-Median-PS-Value | 0.58 | |||||
| Price-to-Net-Current-Asset-Value | 8.75 | |||||
| Price-to-Net-Cash | 13.25 | |||||
| Earnings Yield (Greenblatt) % | -12.17 | |||||
| FCF Yield % | -10.73 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Chiome Bioscience Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 587.303 | ||
| EPS (TTM) (円) | -21.13 | ||
| Beta | 0.61 | ||
| 3-Year Sharpe Ratio | 0.22 | ||
| 3-Year Sortino Ratio | 0.51 | ||
| Volatility % | 122.44 | ||
| 14-Day RSI | 31.71 | ||
| 14-Day ATR (円) | 8.465692 | ||
| 20-Day SMA (円) | 153.25 | ||
| 12-1 Month Momentum % | 12.59 | ||
| 52-Week Range (円) | 75 - 304 | ||
| Shares Outstanding (Mil) | 67.36 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Chiome Bioscience Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Chiome Bioscience Inc Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Chiome Bioscience Inc Frequently Asked Questions
What is Chiome Bioscience Inc(TSE:4583)'s stock price today?
The current price of TSE:4583 is 円145.00. The 52 week high of TSE:4583 is 円304.00 and 52 week low is 円75.00.
When is next earnings date of Chiome Bioscience Inc(TSE:4583)?
The next earnings date of Chiome Bioscience Inc(TSE:4583) is .
Does Chiome Bioscience Inc(TSE:4583) pay dividends? If so, how much?
Chiome Bioscience Inc(TSE:4583) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers